[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
Identifieur interne : 000421 ( Main/Exploration ); précédent : 000420; suivant : 000422[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
Auteurs : T. Bach [Allemagne] ; T. Bschleipfer ; R. MuschterSource :
- Der Urologe. Ausg. A [ 1433-0563 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Hyperplasie de la prostate.
- tendances : Interventions chirurgicales mini-invasives, Prostatectomie, Thérapie laser.
- Humains, Hyperplasie de la prostate, Mâle.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Prostatic Hyperplasia.
- surgery : Prostatic Hyperplasia.
- trends : Laser Therapy, Minimally Invasive Surgical Procedures, Prostatectomy.
- Humans, Male.
Abstract
Open simple prostatectomy is not only the oldest but also the most effective treatment option for benign prostatic obstruction. Laser enucleation has been established as a transurethral minimally invasive alternative especially but not exclusively for large volume prostates. To date two laser systems, holmium:YAG laser enucleation of the prostate (HoLEP) and thulium:YAG laser vapoenucleation of the prostate (ThuVEP) have been established. Both treatment modalities have similarities in terms of wavelength and surgical technique but differ in the type of energy released (pulsed versus continuous wave). The HoLEP and ThuVEP procedures lead to a significant improvement in symptoms, quality of life, urinary flow and post-void residual urine. Surgery-related morbidity, especially bleeding complications is significantly reduced with laser enucleation. For HoLEP the durability of the results was shown for a follow-up interval of up to 10 years while for ThuVEP the follow-up interval reached 18 months due to the shorter time since clinical implementation of this method.
DOI: 10.1007/s00120-013-3114-8
PubMed: 23429881
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000303
- to stream PubMed, to step Curation: 000303
- to stream PubMed, to step Checkpoint: 000303
- to stream Ncbi, to step Merge: 000653
- to stream Ncbi, to step Curation: 000653
- to stream Ncbi, to step Checkpoint: 000653
- to stream Main, to step Merge: 000421
- to stream Main, to step Curation: 000421
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation wicri:level="1"><nlm:affiliation>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg, Deutschland. t.bach@asklepios.com</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg</wicri:regionArea><wicri:noRegion>21075 Hamburg</wicri:noRegion><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Bschleipfer, T" sort="Bschleipfer, T" uniqKey="Bschleipfer T" first="T" last="Bschleipfer">T. Bschleipfer</name></author><author><name sortKey="Muschter, R" sort="Muschter, R" uniqKey="Muschter R" first="R" last="Muschter">R. Muschter</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1007/s00120-013-3114-8</idno><idno type="RBID">pubmed:23429881</idno><idno type="pmid">23429881</idno><idno type="wicri:Area/PubMed/Corpus">000303</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000303</idno><idno type="wicri:Area/PubMed/Curation">000303</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000303</idno><idno type="wicri:Area/PubMed/Checkpoint">000303</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000303</idno><idno type="wicri:Area/Ncbi/Merge">000653</idno><idno type="wicri:Area/Ncbi/Curation">000653</idno><idno type="wicri:Area/Ncbi/Checkpoint">000653</idno><idno type="wicri:Area/Main/Merge">000421</idno><idno type="wicri:Area/Main/Curation">000421</idno><idno type="wicri:Area/Main/Exploration">000421</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation wicri:level="1"><nlm:affiliation>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg, Deutschland. t.bach@asklepios.com</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg</wicri:regionArea><wicri:noRegion>21075 Hamburg</wicri:noRegion><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Bschleipfer, T" sort="Bschleipfer, T" uniqKey="Bschleipfer T" first="T" last="Bschleipfer">T. Bschleipfer</name></author><author><name sortKey="Muschter, R" sort="Muschter, R" uniqKey="Muschter R" first="R" last="Muschter">R. Muschter</name></author></analytic><series><title level="j">Der Urologe. Ausg. A</title><idno type="eISSN">1433-0563</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Laser Therapy (trends)</term><term>Male</term><term>Minimally Invasive Surgical Procedures (trends)</term><term>Prostatectomy (trends)</term><term>Prostatic Hyperplasia (diagnosis)</term><term>Prostatic Hyperplasia (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term><term>Hyperplasie de la prostate ()</term><term>Hyperplasie de la prostate (diagnostic)</term><term>Interventions chirurgicales mini-invasives (tendances)</term><term>Mâle</term><term>Prostatectomie (tendances)</term><term>Thérapie laser (tendances)</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hyperplasie de la prostate</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Interventions chirurgicales mini-invasives</term><term>Prostatectomie</term><term>Thérapie laser</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Laser Therapy</term><term>Minimally Invasive Surgical Procedures</term><term>Prostatectomy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Hyperplasie de la prostate</term><term>Mâle</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Open simple prostatectomy is not only the oldest but also the most effective treatment option for benign prostatic obstruction. Laser enucleation has been established as a transurethral minimally invasive alternative especially but not exclusively for large volume prostates. To date two laser systems, holmium:YAG laser enucleation of the prostate (HoLEP) and thulium:YAG laser vapoenucleation of the prostate (ThuVEP) have been established. Both treatment modalities have similarities in terms of wavelength and surgical technique but differ in the type of energy released (pulsed versus continuous wave). The HoLEP and ThuVEP procedures lead to a significant improvement in symptoms, quality of life, urinary flow and post-void residual urine. Surgery-related morbidity, especially bleeding complications is significantly reduced with laser enucleation. For HoLEP the durability of the results was shown for a follow-up interval of up to 10 years while for ThuVEP the follow-up interval reached 18 months due to the shorter time since clinical implementation of this method.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Hambourg</li></region><settlement><li>Hambourg</li></settlement></list><tree><noCountry><name sortKey="Bschleipfer, T" sort="Bschleipfer, T" uniqKey="Bschleipfer T" first="T" last="Bschleipfer">T. Bschleipfer</name><name sortKey="Muschter, R" sort="Muschter, R" uniqKey="Muschter R" first="R" last="Muschter">R. Muschter</name></noCountry><country name="Allemagne"><region name="Hambourg"><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000421 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000421 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23429881
|texte= [Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23429881" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |